Posters
Micro-monovision as an affordable alternative to multifocal lenses
Poster Details
First Author: E.Likhorad BELARUS
Co Author(s): V. Krasilnikova I. Dulub G. Kryshtopenko
Abstract Details
Purpose:
Presenting a clinical case of refractive clear lenseectomy (RLE) combined with eximer laser correction (ELC) in the short eyes with a micro-monovision creation in a patient with the aim to become spectacles independent and restricted financial possibilities.
Setting:
E. Likhorad, V. Krasilnikova, Belarusian Medical Academy of Postgraduate Education, Belarus
I. Dulub, G. Kryshtopenko, Medical center MTZ, Belarus
Methods:
Retrospective evaluation of the case note of a 30-year-old woman with a high hyperopia, corneal astigmatism on both eyes and mild amblyopia on the left eye. Given the combination of a short axial lenght (OD 20.01 mm, OS 19.83 mm) and steep cornea (OD: K1=43.89,K2=45.42, astigmatism= -1.53;
OS: K1=43.83, K2=45.18, astigmatism= -1.35) the choice of the IOL model was limited to the required power. Spherical IOLs Acrysof Natural SN60AT (Alcon Laboratories, Inc.) with a +35.0 diopters spherical refractive error for both eyes were chosen. RLE were performed without complications with a one week difference.
Results:
In 2 weeks (right eye, left eye):
Uncorrected distance visual acuity (UDVA) 20/50, 20/30;
with correction -0.75 cyl-1.75 ax133=20/20, cyl-1.0 ax51=20/25.
Wearing a soft contact lens on the right eye after 2 weeks was recommended.
In 2 month:
UDVA 20/40, 20/30;
with correction -1.0 cyl -1,5 ax130=20/20, cyl-1.0 ax58=20/30.
Three months later an ELC on the right eye was performed.
In a year:
UDVA: 20/20, 20/25.
Uncorrected near visual acuity: 20/50, 20/40.
Manifest refraction:+0.5 cyl -0.75 ax140, 0.0 cyl -0.75 ax32.
Spherical equivalent: +0.125, -0.375.
Patient is highly satisfied and doesn't use glasses in everyday life.
Conclusions:
Monofocal IOL implantation with micro-monovision creation can help to achieve good results in distance and near visual acuity and can be an alternative for multifocal lens implantation in patients with financial limits or contraindications.
Financial Disclosure:
None